|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,401.00 JPY | -0.19% |
|
-0.82% | +45.74% |
| 01-16 | Takasago to Tender All Hisamitsu Pharma Shares | MT |
| 01-07 | Japan's Nikkei slips 1% from record as investors book profit | RE |
| Capitalization | 449B 2.84B 2.43B 2.25B 2.11B 3.92B 260B 4.19B 25.84B 10.22B 123B 10.64B 10.42B | P/E ratio 2026 * |
21.5x | P/E ratio 2027 * | 28.3x |
|---|---|---|---|---|---|
| Enterprise value | 449B 2.84B 2.43B 2.25B 2.11B 3.92B 260B 4.19B 25.84B 10.22B 123B 10.64B 10.42B | EV / Sales 2026 * |
2.78x | EV / Sales 2027 * | 2.73x |
| Free-Float |
61.13% | Yield 2026 * |
1.87% | Yield 2027 * | 1.99% |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | -0.19% | ||
| 1 week | -0.82% | ||
| Current month | +45.74% | ||
| 1 month | +51.61% | ||
| 3 months | +55.29% | ||
| 6 months | +59.79% | ||
| Current year | +45.74% |
| 1 week | 6,299 |  | 6,480 |
| 1 month | 4,202 | | 6,695 |
| Current year | 4,389 | | 6,695 |
| 1 year | 3,783 | | 6,695 |
| 3 years | 3,541 | | 6,695 |
| 5 years | 3,230 | | 7,750 |
| 10 years | 3,230 | | 9,950 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 53 | 30/04/2015 | |
Takaaki Terahara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Naruhito Higo
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Midori Noguchi
BRD | Director/Board Member | 68 | 21/05/2025 |
| Director/Board Member | 53 | 30/04/2007 | |
Kousuke Sugiyama
BRD | Director/Board Member | 73 | 30/04/1999 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.61% | 0.51% | 29 M€ | |
| -.--% | 0.04% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.19% | -0.82% | +39.33% | +63.29% | 2.84B | |
| +0.28% | +4.60% | +43.30% | +215.74% | 966B | |
| +0.76% | +0.30% | +51.60% | +30.85% | 525B | |
| +0.71% | +0.75% | +29.06% | +47.00% | 382B | |
| +0.93% | +1.10% | +28.76% | +17.75% | 371B | |
| +1.66% | -5.48% | +22.69% | +22.85% | 278B | |
| +0.66% | -0.83% | +28.80% | +34.73% | 276B | |
| -1.65% | -1.24% | +14.54% | -0.26% | 276B | |
| +6.11% | +4.88% | -30.84% | -17.82% | 260B | |
| +1.08% | +5.86% | +27.77% | +33.88% | 185B | |
| Average | +1.10% | -0.80% | +25.50% | +44.80% | 352.2B | |
| Weighted average by Cap. | +0.97% | -0.68% | +30.15% | +75.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 161B 1.02B 873M 810M 760M 1.41B 93.5B 1.51B 9.3B 3.68B 44.19B 3.83B 3.75B | 165B 1.04B 890M 826M 775M 1.44B 95.34B 1.54B 9.48B 3.75B 45.06B 3.9B 3.82B |
| Net income | 19.79B 125M 107M 99.35M 93.17M 173M 11.47B 185M 1.14B 451M 5.42B 469M 460M | 15.64B 98.88M 84.54M 78.48M 73.6M 137M 9.06B 146M 901M 356M 4.28B 371M 363M |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
2,799
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/01/26 | 6,401.00 ¥ | -0.19% | 327,900 |
| 21/01/26 | 6,413.00 ¥ | +0.08% | 556,200 |
| 20/01/26 | 6,408.00 ¥ | +0.98% | 511,500 |
| 19/01/26 | 6,346.00 ¥ | +0.73% | 379,000 |
| 16/01/26 | 6,300.00 ¥ | -0.88% | 535,500 |
Delayed Quote Japan Exchange, January 22, 2026 at 06:30 am
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
6,413.00JPY
Average target price
4,250.00JPY
Spread / Average Target
-33.73%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4530 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition